Juliano Ferreira Selected Research

Juliano Ferreira Research Topics

Disease

65	Pain (Aches) 04/2024 - 07/2000
56	Hyperalgesia 04/2024 - 10/2002
30	Neuralgia (Stump Neuralgia) 05/2020 - 10/2002
23	Inflammation (Inflammations) 12/2022 - 07/2000
21	Edema (Dropsy) 12/2022 - 08/2006
12	Hypersensitivity (Allergy) 08/2021 - 08/2013
10	Chronic Pain 01/2021 - 10/2002
9	Neoplasms (Cancer) 04/2024 - 09/2013
8	Cancer Pain 04/2024 - 09/2013
8	Gout 12/2022 - 08/2011
8	Seizures (Absence Seizure) 12/2013 - 12/2007
7	Postoperative Pain 08/2023 - 11/2008
7	Arthritis (Polyarthritis) 01/2020 - 08/2009
6	Acute Pain 12/2017 - 04/2009
4	Melanoma (Melanoma, Malignant) 08/2021 - 01/2016
4	Tardive Dyskinesia 10/2014 - 07/2005
3	Migraine Disorders (Migraine) 08/2023 - 01/2018
3	Neuroinflammatory Diseases 01/2021 - 12/2017
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 12/2013
3	Constipation 12/2020 - 10/2013
3	Ischemia 01/2020 - 11/2011
3	Contact Dermatitis (Eczema, Contact) 09/2019 - 01/2019
3	Wounds and Injuries (Trauma) 12/2017 - 05/2014
3	Surgical Wound 11/2017 - 11/2008
3	Dyskinesias (Dyskinesia) 10/2014 - 07/2005
3	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2014 - 11/2011
3	Cognitive Dysfunction 11/2013 - 01/2013
3	Glutaric Acidemia I 02/2011 - 12/2007
3	Metabolic Diseases (Metabolic Disease) 02/2011 - 12/2007
2	Arthralgia (Joint Pain) 12/2022 - 07/2014
2	Multiple Sclerosis 08/2021 - 05/2020
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2021 - 05/2020

Drug/Important Bio-Agent (IBA)

18	Analgesics (Analgesic Drugs)IBA 04/2024 - 08/2004
18	Freund's AdjuvantIBA 05/2020 - 10/2002
16	Capsaicin (Zostrix)FDA Link 01/2021 - 01/2003
14	AnkyrinsIBA 08/2021 - 08/2013
11	Opioid Analgesics (Opioids)IBA 04/2024 - 08/2004
11	Peptides (Polypeptides)IBA 01/2021 - 10/2011
10	Morphine (MS Contin)FDA LinkGeneric 04/2024 - 01/2003
10	KininsIBA 06/2023 - 07/2000
9	Calcium Channels (Calcium Channel)IBA 04/2024 - 01/2013
9	AntioxidantsIBA 01/2021 - 12/2007
7	Uric Acid (Urate)IBA 12/2022 - 08/2011
7	VenomsIBA 01/2016 - 03/2007
6	CalciumIBA 08/2023 - 01/2003
6	Peroxidase (Myeloperoxidase)IBA 12/2022 - 12/2006
6	EnzymesIBA 01/2021 - 12/2006
6	Thioctic Acid (Lipoic Acid)IBA 01/2021 - 01/2016
6	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 12/2013
6	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 05/2020 - 06/2011
6	CarrageenanIBA 07/2014 - 04/2006
5	Conotoxins (Conotoxin)IBA 01/2021 - 01/2013
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2020 - 11/2008
5	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019 - 11/2013
5	Adenosine Triphosphatases (ATPase)IBA 02/2016 - 12/2007
5	ProstaglandinsIBA 02/2012 - 08/2006
4	icatibantIBA 06/2023 - 12/2002
4	CytokinesIBA 01/2022 - 03/2010
4	acetovanillone (apocynin)IBA 05/2020 - 11/2013
4	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 01/2020 - 08/2006
4	Irritants (Vesicants)IBA 09/2019 - 08/2013
4	Dexamethasone (Maxidex)FDA LinkGeneric 03/2019 - 08/2004
4	Celecoxib (Celebrex)FDA Link 09/2014 - 08/2004
4	glutaric acidIBA 01/2013 - 12/2007
3	2- ((3- (1,3- benzodioxol- 5- yl)- 3- (((6- methoxy- 2- naphthyl)sulfonyl)amino)propanoyl)amino)- 3- (4- ((2,6- dimethylpiperidinyl)methyl)phenyl)- N- isopropyl- N- methylpropanamideIBA 06/2023 - 10/2011
3	FR 173657IBA 06/2023 - 10/2011
3	TRPA1 Cation ChannelIBA 08/2021 - 01/2016
3	Methadone (Dolophine)FDA LinkGeneric 08/2021 - 10/2013
3	Antisense OligonucleotidesIBA 05/2020 - 01/2019
3	TRPV1 receptorIBA 01/2020 - 02/2011
3	cinnamaldehyde (cinnamic aldehyde)FDA Link 03/2019 - 06/2011
3	Complex MixturesIBA 03/2019 - 01/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 04/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2017 - 01/2016
3	Formaldehyde (Formol)FDA Link 07/2017 - 01/2003
3	Ketamine FDA LinkGeneric 01/2017 - 08/2004
3	InterleukinsIBA 01/2016 - 06/2013
3	salicylhydroxamic acid (SHAM)IBA 01/2016 - 09/2012
3	Haloperidol (Haldol)FDA LinkGeneric 10/2014 - 07/2005
3	Antipsychotic Agents (Antipsychotics)IBA 10/2014 - 10/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014 - 03/2010
3	BradykininIBA 05/2014 - 12/2002
3	Serotonin (5 Hydroxytryptamine)IBA 04/2014 - 08/2011
3	Monoamine Oxidase (MAO)IBA 11/2013 - 09/2012
3	Dinoprostone (PGE2)FDA Link 06/2013 - 08/2006
3	TriterpenesIBA 04/2013 - 10/2002
2	R-Type Calcium Channels (R-Type Calcium Channel)IBA 08/2023 - 10/2011
2	Calcitonin Gene-Related PeptideIBA 01/2022 - 08/2006
2	Ion Channels (Ion Channel)IBA 08/2021 - 01/2020

Therapy/Procedure

12	Ligation 12/2017 - 10/2002
9	Therapeutics 12/2020 - 12/2011
8	Analgesia 08/2023 - 04/2005
7	Oral Administration 12/2017 - 10/2002
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2017
4	Spinal Injections 04/2020 - 10/2011
4	Traditional Medicine (Folk Remedies) 10/2013 - 08/2008
3	Intra-Articular Injections 01/2020 - 06/2013
3	Aftercare (After-Treatment) 01/2017 - 09/2012
3	Subcutaneous Injections 05/2014 - 08/2011
2	Injections 12/2022 - 07/2017